Vagus nerve stimulation market to be valued at $23.73b by 2031

Development in minimally invasive solutions drives the sector.

The global vagus nerve stimulation (VNS) market is expected to reach $23.73b by 2031 at a compound annual growth rate of 10.5%, said Verified Market Research.

The sector’s expansion is attributed to the growing prevalence of neurological disorders, rising demand for non-invasive therapeutic solutions, and increasing clinical approvals.

Development in minimally invasive and non-invasive VNS solutions is also driving market growth.

“Manufacturers are launching compact, wearable, and user-friendly devices with enhanced safety profiles, improved battery efficiency, wireless connectivity, and AI-based monitoring capabilities,” the report said.

Moreover, expanding applications in epilepsy, depression, migraine, and chronic pain management further fuel adoption, with governments, hospitals, and private healthcare organisations investing heavily in advanced neurological care infrastructure.

However, high device cost, surgical risk concerns, and strict regulatory pathways may limit growth.

“For many healthcare systems, particularly in developing regions, budget constraints and limited reimbursement coverage restrict large-scale implementation,” it added.